CoChat

Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination

Open access
Ng, Lhotse Hei Lui, Huang, Yuhua, Han, Lei, Chang, Raymond Chuen-Chung, Chan, Ying Shing, Lai, Cora Sau Wan · 2018 · Translational Psychiatry

The DOI matches its Crossref record; 91 of the 93 references it cites were found in a registry or an index.

Abstract

Stress is a major risk factor for the onset of many psychiatric diseases. In rodent models, chronic stress induces depression and impairs excitatory neurotransmission. However, little is known about the effect of stress on synaptic circuitry during the development of behavioral symptoms. Using two-photon transcranial imaging, we studied the effect of repeated restraint stress on dendritic spine plasticity in the frontal cortex in vivo. We found that restraint stress induced dendritic spine loss by decreasing the rate of spine formation and increasing the rate of spine elimination. The N-methyl-d-aspartate receptor antagonist ketamine inhibited stress-induced spine loss mainly by protecting mushroom spines from elimination. Ketamine also induced re-formation of spines in close proximity to previously stress-eliminated spines. Electrophysiological and in vivo imaging experiments showed that ketamine enhanced activity of parvalbumin (PV) interneurons under stress and counterbalanced the stress-induced net loss of PV axonal boutons. In addition, selective chemogenetic excitation of PV interneurons mimicked the protective effects of ketamine on dendritic spines against stress. Collectively, our data provide new insights on the effects of ketamine on synaptic circuitry under stress and a possible mechanism to counteract stress-induced synaptic impairments through PV interneuron activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0321-5

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Effects of repeated restraint stress on dendritic spine plasticity in the frontal association cortex (FrA). a Timeline of restraint stress (RS) treatment and imaging. b Representative image of dendritic branches in the FrA from control and RS groups. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c, d Rate of dendritic spine elimination and formation in control (n = 6, 929 spines) and RS groups (n = 6, 910 spines). e Net change in dendritic spine number in control and RS groups at day 7. f Percentage of newly formed spines at day 2 that survived at day 7. g, h Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 and 7 days of RS. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control, Student’s t test c–h except Mann–Whitney U test for 7-day elimination in c and mushroom spine elimination in h. i Rate of dendritic spine elimination and formation in control, 7d RS and 2d RS + 5d Recovery (n = 4, 504 spines) groups. Elimination: P = 0.0004, H = 10.88, Kruskal–Wallis test. Formation: P < 0.0001, F(2, 13) = 23.39, one-way ANOVA. *P < 0.05 compared with RS. Data are presented in mean ± s.d
Fig. 1 Effects of repeated restraint stress on dendritic spine plasticity in the frontal association cortex (FrA). a Timeline of restraint stress (RS) treatment and imaging. b Representative image of dendritic branches in the FrA from control and RS groups. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c, d Rate of dendritic spine elimination and formation in control (n = 6, 929 spines) and RS groups (n = 6, 910 spines). e Net change in dendritic spine number in control and RS groups at day 7. f Percentage of newly formed spines at day 2 that survived at day 7. g, h Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 and 7 days of RS. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control, Student’s t test c–h except Mann–Whitney U test for 7-day elimination in c and mushroom spine elimination in h. i Rate of dendritic spine elimination and formation in control, 7d RS and 2d RS + 5d Recovery (n = 4, 504 spines) groups. Elimination: P = 0.0004, H = 10.88, Kruskal–Wallis test. Formation: P < 0.0001, F(2, 13) = 23.39, one-way ANOVA. *P < 0.05 compared with RS. Data are presented in mean ± s.dCC BY · PubMed Central
Fig. 2 Ketamine counteracts RS-induced elimination of mature dendritic spines. a Timeline of ketamine treatment and imaging under RS. In single dose ketamine (KET-s) group, ketamine was administered on day 1 before RS session. In the repeated ketamine (KET-r) group, ketamine was injected daily before RS session. b Representative image of dendritic branches in the FrA from saline, KET-s, and KET-r groups under RS. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c, d Rate of dendritic spine formation and elimination in RS + saline (n = 5, 774 spines), RS + KET-s (n = 5, 728 spines), and RS + KET-r groups (n = 6, 892 spines). Formation: Day 2: P = 0.0908, F(2, 13) = 2.901; day 7: P = 0.3535, F(2, 13) = 1.128, one-way ANOVA. Elimination: Day 2, P < 0.0001, F(2,13) = 38.78, one-way ANOVA. Day 7, P < 0.0001, F(2,13) = 22.31, one-way ANOVA. e Net change in dendritic spine number in RS + saline, RS + KET-s, and RS + KET-r groups at day 7. P < 0.0001, F(2,13) = 21.22, one-way ANOVA. f Percentage of newly formed spines at day 2 that survived at day 7 in RS + saline, RS + KET-s, and RS + KET-r groups, P = 0.5496, F(2,13) = 0.627, one-way ANOVA. g Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 and 7 days of RS. Mushroom spines: Day 2, P < 0.0001, F(2,13) = 87.99, one-way ANOVA. Day 7, P < 0.0001, H = 12.88, Kruskal–Wallis test. **P < 0.01, ***P < 0.001 compared with RS + saline. Data are presented in mean ± s.d. h Timeline of ketamine treatment and imaging under pre-stressed condition. i Representative image of dendritic branches in the FrA of saline and KET-r groups under RS. Arrowheads mark sites of spine elimination. White arrows mark sites of newly formed spines. Asterisks mark filopodia. Hollow arrows indicate formation of new spines at day 4 within 2 µm of spines eliminated at day 2. Scale bar 4 µm. j Rate of dendritic spine elimination and formation in RS + saline (n = 6, 735 spines) and RS + KET-r groups (n = 6, 830 spines) from day 2 to day 4. k Net change in dendritic spine number in RS + saline and RS + KET-r groups at day 4. l Cumulative frequency plot showing the relative distance between new spines formed at day 4 and the nearest spine that was eliminated at day 2. m Graph showing the relative distance of spine newly formed at day 4 to the nearest spine eliminated at day 2. RS + saline: 37 spines, RS + KET-r: 72 spines. *P < 0.05, **P < 0.01 compared with RS + saline. Student’s t test. Data are presented in mean ± s.d
Fig. 2 Ketamine counteracts RS-induced elimination of mature dendritic spines. a Timeline of ketamine treatment and imaging under RS. In single dose ketamine (KET-s) group, ketamine was administered on day 1 before RS session. In the repeated ketamine (KET-r) group, ketamine was injected daily before RS session. b Representative image of dendritic branches in the FrA from saline, KET-s, and KET-r groups under RS. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c, d Rate of dendritic spine formation and elimination in RS + saline (n = 5, 774 spines), RS + KET-s (n = 5, 728 spines), and RS + KET-r groups (n = 6, 892 spines). Formation: Day 2: P = 0.0908, F(2, 13) = 2.901; day 7: P = 0.3535, F(2, 13) = 1.128, one-way ANOVA. Elimination: Day 2, P < 0.0001, F(2,13) = 38.78, one-way ANOVA. Day 7, P < 0.0001, F(2,13) = 22.31, one-way ANOVA. e Net change in dendritic spine number in RS + saline, RS + KET-s, and RS + KET-r groups at day 7. P < 0.0001, F(2,13) = 21.22, one-way ANOVA. f Percentage of newly formed spines at day 2 that survived at day 7 in RS + saline, RS + KET-s, and RS + KET-r groups, P = 0.5496, F(2,13) = 0.627, one-way ANOVA. g Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 and 7 days of RS. Mushroom spines: Day 2, P < 0.0001, F(2,13) = 87.99, one-way ANOVA. Day 7, P < 0.0001, H = 12.88, Kruskal–Wallis test. **P < 0.01, ***P < 0.001 compared with RS + saline. Data are presented in mean ± s.d. h Timeline of ketamine treatment and imaging under pre-stressed condition. i Representative image of dendritic branches in the FrA of saline and KET-r groups under RS. Arrowheads mark sites of spine elimination. White arrows mark sites of newly formed spines. Asterisks mark filopodia. Hollow arrows indicate formation of new spines at day 4 within 2 µm of spines eliminated at day 2. Scale bar 4 µm. j Rate of dendritic spine elimination and formation in RS + saline (n = 6, 735 spines) and RS + KET-r groups (n = 6, 830 spines) from day 2 to day 4. k Net change in dendritic spine number in RS + saline and RS + KET-r groups at day 4. l Cumulative frequency plot showing the relative distance between new spines formed at day 4 and the nearest spine that was eliminated at day 2. m Graph showing the relative distance of spine newly formed at day 4 to the nearest spine eliminated at day 2. RS + saline: 37 spines, RS + KET-r: 72 spines. *P < 0.05, **P < 0.01 compared with RS + saline. Student’s t test. Data are presented in mean ± s.dCC BY · PubMed Central
Fig. 3 Ketamine increases PV interneurons activity ex vivo and in vivo after restraint stress. a Bright field and fluorescent image of PV interneurons expressing tdTomato in frontal cortical slice from restraint stressed PV-Cre;Ai9-tdTomato mice under whole-cell recording. Expression of tdTomato is specific to PV interneurons in PV-Cre;Ai9-tdTomato mice. b Representative traces showing evoked action potential (APs) firing of PV interneurons (100 pA) before, and 10-min, 30-min, 50-min after bath application of ketamine (10 µM). c Graph showing frequency of APs evoked by a range of injection currents of PV interneurons before and after ketamine. P < 0.0001, Fketamine treatment time(3, 48) = 13.92, two-way repeated measure ANOVA. ***P < 0.0001 compared with before ketamine, post hoc Dunnett’s test. n = 17 neurons. Data are presented in mean ± s.e.m. d Representative in vivo two-photon image of the specific expression of Cre-dependent GCaMP6f in PV interneurons in L2/3 FrA of PV-Cre;Ai9-tdTomato mice. Green: GCaMP6f. Red: tdTomato. Scale bar: 60 µm. e Schematic diagram of Ca2+ imaging under RS in vivo. f Timeline for GCaMP6f imaging. GCaMP6f signal was collected at 4 h and 8 h. Saline or ketamine was injected right after the imaging session at 4 h. g Heat maps showing ΔF/F0 of individual neurons over the 2-min imaging session in RS + saline (n = 43 cells from seven mice) and RS + KET (n = 45 cells from nine mice) groups using 4 h reading as baseline. h Average ΔF/F0 in RS + saline and RS + KET groups after ketamine or saline treatment compared with 4 h activity. ***P < 0.001 compared with RS + saline, Student’s t test. Data are presented in mean ± s.d
Fig. 3 Ketamine increases PV interneurons activity ex vivo and in vivo after restraint stress. a Bright field and fluorescent image of PV interneurons expressing tdTomato in frontal cortical slice from restraint stressed PV-Cre;Ai9-tdTomato mice under whole-cell recording. Expression of tdTomato is specific to PV interneurons in PV-Cre;Ai9-tdTomato mice. b Representative traces showing evoked action potential (APs) firing of PV interneurons (100 pA) before, and 10-min, 30-min, 50-min after bath application of ketamine (10 µM). c Graph showing frequency of APs evoked by a range of injection currents of PV interneurons before and after ketamine. P < 0.0001, Fketamine treatment time(3, 48) = 13.92, two-way repeated measure ANOVA. ***P < 0.0001 compared with before ketamine, post hoc Dunnett’s test. n = 17 neurons. Data are presented in mean ± s.e.m. d Representative in vivo two-photon image of the specific expression of Cre-dependent GCaMP6f in PV interneurons in L2/3 FrA of PV-Cre;Ai9-tdTomato mice. Green: GCaMP6f. Red: tdTomato. Scale bar: 60 µm. e Schematic diagram of Ca2+ imaging under RS in vivo. f Timeline for GCaMP6f imaging. GCaMP6f signal was collected at 4 h and 8 h. Saline or ketamine was injected right after the imaging session at 4 h. g Heat maps showing ΔF/F0 of individual neurons over the 2-min imaging session in RS + saline (n = 43 cells from seven mice) and RS + KET (n = 45 cells from nine mice) groups using 4 h reading as baseline. h Average ΔF/F0 in RS + saline and RS + KET groups after ketamine or saline treatment compared with 4 h activity. ***P < 0.001 compared with RS + saline, Student’s t test. Data are presented in mean ± s.dCC BY · PubMed Central
Fig. 4 Ketamine counteracts the loss of PV axonal boutons induced by stress. a Timeline of PV axonal bouton imaging. Ketamine or saline was administered daily before RS sessions and mice were imaged after RS sessions. b Representative image of PV interneuron axonal branches in the FrA from control (n = 5, 1131 boutons), RS + saline (n = 6, 1429 boutons) and RS + KET-r (n = 5, 953 boutons) groups. Arrowheads mark sites of bouton elimination. White arrows mark sites of newly formed boutons. Scale bar 4 µm. c Rate of PV boutons elimination in control, RS + saline and RS + KET-r groups. Day 7: P = 0.0211, H = 7.05, Kruskal–Wallis test. d Rate of PV bouton formation in control, RS + saline and RS + KET-r groups. Day 5, P = 0.0264, F(2, 13) = 4.869, one-way ANOVA. Day 7, P = 0.0292, F(2, 13) = 4.696, one-way ANOVA. e Net change in PV bouton number in control, RS + saline and RS + KET-r groups. Day 5, P = 0.0080, F(2, 13) = 7.15, one-way ANOVA. Day 7: P = 0.0010, F(2, 13) = 12.35, one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control, #P < 0.05 compared with RS + KET-r. Data are presented in mean ± s.d
Fig. 4 Ketamine counteracts the loss of PV axonal boutons induced by stress. a Timeline of PV axonal bouton imaging. Ketamine or saline was administered daily before RS sessions and mice were imaged after RS sessions. b Representative image of PV interneuron axonal branches in the FrA from control (n = 5, 1131 boutons), RS + saline (n = 6, 1429 boutons) and RS + KET-r (n = 5, 953 boutons) groups. Arrowheads mark sites of bouton elimination. White arrows mark sites of newly formed boutons. Scale bar 4 µm. c Rate of PV boutons elimination in control, RS + saline and RS + KET-r groups. Day 7: P = 0.0211, H = 7.05, Kruskal–Wallis test. d Rate of PV bouton formation in control, RS + saline and RS + KET-r groups. Day 5, P = 0.0264, F(2, 13) = 4.869, one-way ANOVA. Day 7, P = 0.0292, F(2, 13) = 4.696, one-way ANOVA. e Net change in PV bouton number in control, RS + saline and RS + KET-r groups. Day 5, P = 0.0080, F(2, 13) = 7.15, one-way ANOVA. Day 7: P = 0.0010, F(2, 13) = 12.35, one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001 compared with control, #P < 0.05 compared with RS + KET-r. Data are presented in mean ± s.dCC BY · PubMed Central
Fig. 5 Chemogenetic activation of parvalbumin (PV)-interneurons mimics ketamine’s effect on dendritic spine plasticity under stress. a Schematic diagram showing the site of DREADD vectors injection. Upon CNO administration, hM3D(Gq) and hM4D(Gi) are activated to induce excitation and inhibition of PV interneurons, respectively. b Representative image of dendritic branches in the FrA of vector control, excitation of PV interneurons (PV-Ex) and inhibition of PV interneurons (PV-In) groups under RS. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c Rate of dendritic spine elimination at day 2 and day 7 in RS + vector + saline, RS + CNO, RS + PV-Ex, and RS + PV-In groups. Day 2: P < 0.0001, F(3, 31) = 37.56, one-way ANOVA. Day 7: P < 0.0001, F(3, 19) = 15.38, one-way ANOVA. d) Rate of dendritic spine formation at day 2 and day 7 in RS + vector + saline, RS + CNO, RS + PV-Ex, and RS + PV-In groups. Day 2: P < 0.0001, F(3, 31) = 13.94, one-way ANOVA. Day 7: P = 0.2576, F(3, 19) = 1.458, one-way ANOVA. RS + Vector + saline (Day 2: n = 10, 1439 spines; day 7: n = 6, 768 spines), RS + CNO (n = 6, 946 spines for both day 2 and 7), RS + PV-Ex groups (Day 2: n = 10, 1384 spines; day 7: n = 6, 837 spines) and RS + PV-In (Day 2: n = 9, 1264 spines; day 7: n = 5, 743 spines). e) Rate of spine elimination at day 2 in non-stress control (n = 6, 929 spines), PV-Ex (n = 5, 615 spines) and PV-In (n = 4, 472 spines) groups. P = 0.0904, F(2,12) = 2.957, one-way ANOVA. f Percentage of eliminated spines classified as mushroom, stubby and thin spines after 2- and 7- day RS. Mushroom spines: Day 2, P < 0.0001, F(2,26) = 18.23, one-way ANOVA. Day 7, P = 0.0007, H = 10.9, Kruskal–Wallis test. g Rate of dendritic spine elimination at day 2 in RS + KET-r (n = 6, 892 spines), RS + KET-r + PV-Ex (n = 5, 777 spines) and RS + KET-r + PV-In (n = 5, 638 spines) groups. Elimination: P = 0.0178, F(2,13) = 5.579, one-way ANOVA. h Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 days of RS in RS + KET-r, RS + KET-r + PV-Ex, and RS + KET-r + PV-In groups. Mushroom spines: P = 0.0236, F(2, 13) = 5.064, one-way ANOVA. * P < 0.05 compared with RS + KET-r. i Rate of dendritic spine elimination at day 2 and day 7 in RS + vector + saline, RS + SST-In, RS + VIP-In groups. Day 2: P = 0.0008, F(2, 18) = 11.02, one-way ANOVA. Day 7: P = 0.0207, F(2, 14) = 5.178, one-way ANOVA. j Rate of dendritic spine formation at day 2 and day 7 in RS + vector + saline, RS + SST-In, RS + VIP-In groups. Day 2: P < 0.0001, F(2, 18) = 18.91, one-way ANOVA. Day 7: P = 0.0001, F(2, 14) = 17.98, one-way ANOVA. RS + SST-In (Day 2: n = 5696 spines; day 7: n = 5, 676 spines), RS + VIP-In (Day 2: n = 6, 789 spines; day 7: n = 6, 744 spines). c, d, f, i, j *P < 0.05, **P < 0.01, ***P < 0.001 compared with RS + vector + saline. Data are presented in mean ± s.d
Fig. 5 Chemogenetic activation of parvalbumin (PV)-interneurons mimics ketamine’s effect on dendritic spine plasticity under stress. a Schematic diagram showing the site of DREADD vectors injection. Upon CNO administration, hM3D(Gq) and hM4D(Gi) are activated to induce excitation and inhibition of PV interneurons, respectively. b Representative image of dendritic branches in the FrA of vector control, excitation of PV interneurons (PV-Ex) and inhibition of PV interneurons (PV-In) groups under RS. Arrowheads mark sites of spine elimination. Arrows mark sites of newly formed spines. Asterisks mark filopodia. Scale bar 4 µm. c Rate of dendritic spine elimination at day 2 and day 7 in RS + vector + saline, RS + CNO, RS + PV-Ex, and RS + PV-In groups. Day 2: P < 0.0001, F(3, 31) = 37.56, one-way ANOVA. Day 7: P < 0.0001, F(3, 19) = 15.38, one-way ANOVA. d) Rate of dendritic spine formation at day 2 and day 7 in RS + vector + saline, RS + CNO, RS + PV-Ex, and RS + PV-In groups. Day 2: P < 0.0001, F(3, 31) = 13.94, one-way ANOVA. Day 7: P = 0.2576, F(3, 19) = 1.458, one-way ANOVA. RS + Vector + saline (Day 2: n = 10, 1439 spines; day 7: n = 6, 768 spines), RS + CNO (n = 6, 946 spines for both day 2 and 7), RS + PV-Ex groups (Day 2: n = 10, 1384 spines; day 7: n = 6, 837 spines) and RS + PV-In (Day 2: n = 9, 1264 spines; day 7: n = 5, 743 spines). e) Rate of spine elimination at day 2 in non-stress control (n = 6, 929 spines), PV-Ex (n = 5, 615 spines) and PV-In (n = 4, 472 spines) groups. P = 0.0904, F(2,12) = 2.957, one-way ANOVA. f Percentage of eliminated spines classified as mushroom, stubby and thin spines after 2- and 7- day RS. Mushroom spines: Day 2, P < 0.0001, F(2,26) = 18.23, one-way ANOVA. Day 7, P = 0.0007, H = 10.9, Kruskal–Wallis test. g Rate of dendritic spine elimination at day 2 in RS + KET-r (n = 6, 892 spines), RS + KET-r + PV-Ex (n = 5, 777 spines) and RS + KET-r + PV-In (n = 5, 638 spines) groups. Elimination: P = 0.0178, F(2,13) = 5.579, one-way ANOVA. h Percentage of eliminated spines classified as mushroom, stubby, and thin spines after 2 days of RS in RS + KET-r, RS + KET-r + PV-Ex, and RS + KET-r + PV-In groups. Mushroom spines: P = 0.0236, F(2, 13) = 5.064, one-way ANOVA. * P < 0.05 compared with RS + KET-r. i Rate of dendritic spine elimination at day 2 and day 7 in RS + vector + saline, RS + SST-In, RS + VIP-In groups. Day 2: P = 0.0008, F(2, 18) = 11.02, one-way ANOVA. Day 7: P = 0.0207, F(2, 14) = 5.178, one-way ANOVA. j Rate of dendritic spine formation at day 2 and day 7 in RS + vector + saline, RS + SST-In, RS + VIP-In groups. Day 2: P < 0.0001, F(2, 18) = 18.91, one-way ANOVA. Day 7: P = 0.0001, F(2, 14) = 17.98, one-way ANOVA. RS + SST-In (Day 2: n = 5696 spines; day 7: n = 5, 676 spines), RS + VIP-In (Day 2: n = 6, 789 spines; day 7: n = 6, 744 spines). c, d, f, i, j *P < 0.05, **P < 0.01, ***P < 0.001 compared with RS + vector + saline. Data are presented in mean ± s.dCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Cited by

See all 84

Metadata

Authors
Ng, L. H. L., Huang, Y., Han, L., Chang, R. C.-C., Chan, Y. S., & Lai, C. S. W.
Affiliations
University of Hong Kong (HK)
Corresponding author
Lai, Cora Sau Wan
Venue
Translational Psychiatry
Published
2018-12-10
Volume
8
Issue
1
Pages
272-272
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2903823537
Cited by
82
References
93
Citations by year
2026: 8 · 2025: 6 · 2024: 12 · 2023: 13 · 2022: 15 · 2021: 8 · 2020: 13 · 2019: 5 · 2018: 1
FWCI
3.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Research Grants Council, University Grants Committee (27103715, 17128816)
  • National Natural Science Foundation of China (31571031)
  • Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (03143096)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
ketamine, parvalbumin interneurons, restraint stress, chronic stress, depression, NMDA receptor antagonists, mushroom spines, synaptic plasticity, frontal cortex, axonal boutons
MeSH terms
Animals, Female, Frontal Lobe, Interneurons, Ketamine, Male, Mice, Inbred C57BL, Neuronal Plasticity, Parvalbumins, Restraint, Physical, Stress, Psychological, Excitatory Amino Acid Antagonists, Dendritic Spines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination. https://app.cochat.ai/papers/10.1038/s41398-018-0321-5
The paper
Ng, L. H. L., Huang, Y., Han, L., Chang, R. C.-C., Chan, Y. S., & Lai, C. S. W. (2018). Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0321-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.